Loading company profile...

📊 Aardvark Therapeutics, Inc. Common Stock (AARD) — AI Scoring Summary

📊 AI Stock Rating — Summary

AARD reported revenue of $0 with a net income loss of $16.32 million and an EPS of -$0.75 in its latest quarter ending September 30, 2025. The company's free cash flow was similarly negative at -$16.13 million. Despite these challenges, AARD maintains a strong balance sheet with total assets of $133.23 million and a negative net debt position of $38.74 million, indicating more cash and equivalents than debt. With no dividends or buybacks reported, the firm's shareholder returns are expected to come mainly from potential price appreciation, with analyst targets up to $24 suggesting further upside at the time of this analysis. The consensus price target of $21 implies some optimism relative to the current share price.

AI Score Breakdown

Revenue Growth — Score: 1/10

AARD's revenue is currently at $0, highlighting a need for future growth and stability in this area. Current growth drivers are unclear given the lack of sales.

Profitability — Score: 2/10

The company exhibited a net margin deficit, with a net loss of $16.32 million. Efficiency is lacking, shown by a negative EPS of -$0.75, reflecting ongoing operational challenges.

Cash Flow Quality — Score: 3/10

Free cash flow remains negative at -$16.13 million. However, the cash position of $39.29 million provides some liquidity cushion. Absence of dividends and repurchases suggests weak direct shareholder returns.

Leverage & Balance Sheet — Score: 7/10

Strong balance sheet with total equity of $122.38 million and net debt of -$38.74 million, reflecting no leverage and solid financial resilience.

Shareholder Returns — Score: 5/10

With no dividends or buybacks, the potential for shareholder returns lies in stock price appreciation. Analyst price targets point to possible upside yet backed by solid price targets between $18-$24.

Analyst Sentiment & Valuation — Score: 6/10

While traditional valuation metrics are missing, analyst price targets suggest a fair valuation with potential for appreciation, indicating cautious optimism from the analyst community.

⚠ AI-generated — informational only, not financial advice.

SEC Filings